LISATHYONE

LISATHYONE
Product Description

ACTIVE PRINCIPLE INGREDIENT: glutathione sodium salt   INDICATONS: prophylaxis of neuropathies following chemoterapy with cisplatin or cisplatin analogues PHARMACEUTICAL FORM - DOSAGE: Powder and solution for injection 600mg/3ml IM - IV PACKAGE: 1 powder vial + 1 solv. ampoule   -  10 powder vials + 10 solv. ampoules  

Lisapharma Spa

  • IT
  • 2015
    On CPHI since
  • 4
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator

Lisapharma Spa

  • IT
  • 2015
    On CPHI since
  • 4
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator

More Products from Lisapharma Spa (4)

  • LISAMETHYLE

    Product LISAMETHYLE

    ACTIVE PRINCIPLE INGREDIENT: Methylprednisolone sodium succinate INDICATIONS: Corticosteroid,  anti-inflammatory drug PHARMACEUTICAL FORM - DOSAGE:  20mg/2ml; 40mg/2ml; 120mg/2ml powder and solvent for solution for injection injection IM - IV;  500mg powder for solution for inj...
  • ARFEN

    Product ARFEN

    ACTIVE PRINCIPLE INGREDIENT: ibuprofen lysinate. INDICATIONS: NSAID. Chronic symptomatic treatment of rheumatoid arthritis and osteoarthritis.  PHARMACEUTICAL FORM - DOSAGE: injectable ampoules 3ml - 600mg    PACKAGE: 6 vials/box
  • SUCRATE GEL

    Product SUCRATE GEL

    ACTIVE PRINCIPLE INGREDIENT: Sucralfate gel.INDICATIONS: Gastric ulcer, duodenal ulcer, acute gastritis, symptomatic chronic gastritis, NSAID-related gastric pathologies, reflux esophagitis. PHARMACEUTICAL FORM - DOSAGE - PACKAGE: oral sachets   1g/5ml, 30 sachets/box  -   2...
  • LIKACIN

    Product LIKACIN

    ACTIVE PRINCIPLE INGREDIENT: Amikacin sulfate.INDICATIONS: Semi-synthetic aminoglycoside antibiotic with broad anti- gram positive/gram- negative spectrum.   PHARMACEUTICAL FORM - DOSAGE - PACKAGING: 1 vial 250mg/2ml IM-IV, 1 vial 500mg/2ml IM-IV, 1 vial 1g/4ml IM-IV.  1 vial 250mg/2ml IM...